Find Paid Clinical Trials in Russia

Browse Locations ... Russian Federation

Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012
Safety and Efficacy Study OnabotulinumtoxinA for the Treatment of Urinary Incontinence in Multiple Sclerosis

Conditions: Urinary Incontinence; Multiple Sclerosis
Interventions: Biological: OnabotulinumtoxinA; Drug: Placebo (Normal Saline); OnabotulinumtoxinA
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012
A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

Condition: Mantle Cell Lymphoma
Intervention: Drug: Ibrutinib
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012
A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

Condition: Arthritis, Rheumatoid
Interventions: Drug: JNJ-40346527; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified May 2012
Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life

Condition: Endometriosis
Intervention: Drug: Visanne (Dienogest, BAY86-5258)
Sponsors: Bayer; Bayer
Not yet recruiting - verified May 2012
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction

Condition: Contraception
Interventions: Drug: Levonorgestrel (Mirena, BAY86-5028); Device: Copper IUD
Sponsors: Bayer; Bayer
Recruiting - verified May 2012
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012
Three Anthracyclines, Two Types of Consolidation With Different ARA-C Doses and Maintenance in Adult AML

Condition: Acute Myeloid Leukemia
Intervention: Drug: daunorubicine, idarubicine, mitoxantrone
Sponsors: National Research Center for Hematology, Russia; National Research Center for Hematology, Russia
Recruiting - verified April 2012
Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)

Condition: Post-Stroke Cognitive Impairment (PSCI)
Interventions: Drug: Actovegin; Drug: Placebo
Sponsors: Nycomed; Nycomed
Not yet recruiting - verified April 2012
A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Condition: Major Depressive Disorder
Interventions: Drug: JNJ-40411813; Drug: Placebo
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Not yet recruiting - verified April 2012
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012
PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

Condition: Ewing Family of Tumors, Rhabdomyosarcoma
Intervention: Drug: Lipegfilgrastim
Sponsors: Teva Pharmaceutical Industries; Merckle GmbH
Not yet recruiting - verified April 2012